返回 Agenda
Session 6: Data Transparency: How do We Measure Up?
Session Chair(s)
Melanie North, PHD
Clinical Trial Transparency and Disclosure , Melanie North Consulting, United States
In this session we will hear from prominent commentators on the status of clinical trial data disclosure in 2017. We will start with a discussion about the reporting of outcome measures and hear the latest on the All Trials TrialsTracker and the Good Pharma Scorecard. As a late-breaking addition we will hear industry’s response and analysis of compliance with clinical trial registration and reporting requirements.
Learning Objective :
Speaker(s)
Henry Drysdale
Honorary Clinical Research Fellow, University of Oxford, United Kingdom
Speaker
April Clyburne-Sherin
AllTrials USA Campaign Manager, Sense About Science USA, United States
Speaker
Jennifer Miller, PHD
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics, Yale School of Medicine, United States
Speaker
Olivia Shopshear, MS
Senior Director, US Regulatory Policy Lead, Biogen, United States
Speaker
Panel Discussion
, All Session Speakers, United States
Q&A Panel Discussion